A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male versus female patients

EuroIntervention

Volumn 7, Issue 9, 2012, Pages 1051-1059

  Kornowski, Ran ^a,b   Vaknin Assa, Hana ^a,b   Assali, Abid ^a,b   Lev, Eli I ^a,b   Porter, Avital ^a,b   Battler, Alexander ^a,b   Bental, Tamir ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bare metal stent; Coronary artery disease; Drug eluting stent

Indexed keywords

ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK BENEFIT ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SMOKING; THERAPY EFFECT;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; MALE; METALS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84856286124     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I9A167     Document Type: Article

References (18)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics- 2010 Update: A Report from the American Heart Association. Circulation. 2010; 121:e46-e215.
2. Lansky AJ. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovasc Dis. 2004;46:305-319. (Pubitemid 38201293)
3. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol. 2010;56:S1-42.
4. Thompson CA, Kaplan AV, Friedman BJ, Jayne JE, Gerling BR, Niles NW, Hettleman BD, Robb JF. Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era. Catheter Cardiovasc Interv. 2006;67:25-31. (Pubitemid 43062604)
5. Berger JS, Sanborn TA, Sherman W, Brown DL. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention. Am Heart J. 2006;151:1026-1031.
6. Legato MJ. Beyond women's health the new discipline of gender-specific medicine. Med Clin North Am. 2003;87:917-3.
7. Chieffo A, Hoye A, Mauri F, Mikhail GW, Ammerer M, Grines C, Grinfeld L, Madan M, Presbitero P, Skelding KA, Weiner BH, Mehran R; WIN Group; Women in Innovations Initiative. Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) Initiative. Catheter Cardiovasc Interv. 2010;75:145-52.
8. Bental T, Assali A, Vaknin-Assa H, Lev EI, Brosh D, Fuchs S, Battler A, Kornowski R. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv. 2010;76:374-380.
9. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
10. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am. Stat Assoc. 1982;79:516-24.
11. Rubin DB, Thomas N. Matching using estimated propensity scores: Relating theory to practice. Biometrics. 1996;52:249-64. (Pubitemid 26125107)
12. Kornowski R, Lansky AJ, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Popma JJ, Leon MB. Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol. 1997;79:1601-5. (Pubitemid 27339467)
13. Brown RA, Williams M, Barker, CM, Mauri L, Meredith IT, Fajadet J, Wijns W, Leon MB, Kandzari DE. Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late term clinical results. Catheter Cardiovasc Interv. 2010;76:804-13.
14. Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R. Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2007;50:2111-2116. (Pubitemid 350117340)
15. Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW; TAXUS-IV Investigators. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol. 2005;45:1180-1185. (Pubitemid 40523134)
16. Lansky AJ, Ng VG, Mutlu H, Cristea E, Guiran JB, Midei M, Newman W, Sanz M, Sood P, Doostzadeh J, Su X, White R, Cao S, Sudhir K, Stone GW. Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial. Catheter Cardiovasc Interv. 2009;74:719-727.
17. Seth A, Serruys PW, Lansky A, Hermiller J, Onuma Y, Miquel-Hebert K, Yu S, Veldhof S, Sood P, Sudhir K, Stone GW. A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis. EuroIntervention. 2010;5:788-94.
18. Onuma Y, Kukreja N, Daemen J, Garcia-Garcia HM, Gonzalo N, Cheng JM, van Twisk PH, van Domburg R, Serruys PW, on behalf of the Interventional Cardiologists of Thoraxcenter. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and TSEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) registries. J Am Coll Cardiol Interv. 2009;2:603-610.